PentaBind is a VC-backed drug discovery company using Artificial Intelligence and an integrated wet-laboratory to design high performance aptamers with multiple drug-like qualities in one step. They develop their own pipeline therapeutic assets with aptamers as an active ingredient and aptamers as a delivery vehicle. Shortlisted as New Startup of the Year by Cancer Research Horizons. PentaBind is is supported by Entrepreneur First VC, Twin Path, P4SY, Panacea Stars, Stevenage Bioscience Catalyst, Science Creates Accelerator, Science Entrepreneur Club, and KQ Labs (the Francis Crick Institute). For more information or to join our mission: contact@PentaBind.com ***We are hiring Computational Biologists, Molecular Biologists, Protein and Data Engineers. Don't hesitate to reach out!***
| Website | https://www.pentabind.com/ |
| Employees | 15 (11 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Innovative Drug Discovery, Drug Discovery Technology, Biotechnology Ai, Pharmaceutical Ai, Aptamer Therapeutics |
| Competitors | FedEx, Canva, Down Syndrome Association of Central NJ, Vistaprint SAR.L., Zazzle, Cimpress, Printful, MOO, Snapfish, Overnight Prints +28 more (view full list) |
Looking for a particular PentaBind employee's phone or email?
Rory Ryan is the CEO and Co-founder of PentaBind.
11 people are employed at PentaBind.
PentaBind is based in London, England.